This HTML5 document contains 40 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n15http://linked.opendata.cz/resource/drugbank/drug/DB01954/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB01954/identifier/bindingdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB01954/identifier/pubchem-compound/
n6http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB01954/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB01954/identifier/kegg-drug/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB01954/identifier/drugbank/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB01954/identifier/chemspider/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB01954
rdf:type
n3:Drug
n3:description
A phosphodiesterase inhibitor with antidepressant properties. [PubChem]
n3:group
experimental
owl:sameAs
n6:DB01954 n14:DB01954
dcterms:title
4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]-2-Pyrrolidinone
adms:identifier
n8:394978 n9:DB01954 n10:50042056 n11:448055 n12:46508075 n13:D01783 n15:ROL
n3:IUPAC-Name
n4:271B5675-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B567B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B567A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5677-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5678-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5679-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5673-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5671-363D-11E5-9242-09173F13E4C5 n4:271B5674-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5672-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5681-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5682-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B567C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B567D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B567F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B567E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5680-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
61413-54-5
n3:Bioavailability
n4:271B5687-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5689-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B568A-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5686-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5685-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5688-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5676-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5683-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5684-363D-11E5-9242-09173F13E4C5